Recognizing industrial education Saskatchewan to research patient adherence issuesA new initiative at the University of Saskatchewan's College of Pharmacy and Nutrition is expected to boost research into ways to improve patient medication adherence. Saskatchewan to research patient adherence issues A new initiative at the University of Saskatchewan's College of Pharmacy and Nutrition is expected to boost research into ways to improve patient medication adherence. NEW DRUGS: Schizophrenia med extended to bipolar patients Inspra: new oral aldosterone antagonist coming soon Pfizer plans to launch a new aldosterone antagonist, Inspra (eplerenone 25 mg and 50 mg tablets). Lyrica approved for fibromyalgia Pfizer's Lyrica (pregabalin) is now approved for the management of pain in adults with fibromyalgia. PROOF Centre partners with Pfizer Research to prevent vital organ failure Pfizer to acquire Wyeth for $68 billion Pfizer Inc., the world's leading drug maker, is buying Wyeth for $68 billion US. Vaccine reduces risk of shingles in older adults First Previous 17 18 19
